Showing results (121-130 of 11,001) with videos related to
Sort By:
Pageof 1,101
Brain : a Journal of Neurology|June 1, 1977
Ballistic movement overflow myoclonus a form of essential myoclonusM Hallett, D Chadwick, C D MarsdenJournal of Inherited Metabolic Disease|January 26, 2006
The knowledge gap in expanded newborn screening: survey results from paediatricians in MassachusettsM Gennaccaro, S E Waisbren, D MarsdenMethods in Molecular Biology (Clifton, N.J.)|May 5, 2017
N- and C-Terminal Truncations to Enhance Protein Solubility and Crystallization: Predicting Protein Domain Boundaries with Bioinformatics ToolsChristopher D O Cooper, Brian D MarsdenEuropean Journal of Pharmacology|January 1, 1976
Modification of the L-DOPA reversal of reserpine akinesia by inhibitors of dopamine-beta-hydroxylaseA Dolphin, P Jenner, C D MarsdenBritish Journal of Clinical Pharmacology|January 1, 1983
Noradrenaline and 5-hydroxytryptamine modulation of brain dopamine function: implications for the treatment of Parkinson's diseaseP Jenner, M Sheehy, C D MarsdenCiba Foundation Symposium|January 1, 1984
Gamma-aminobutyric acid and basal ganglia outflow pathwaysC Reavill, P Jenner, C D MarsdenNeuropharmacology|December 1, 1982
Tryptamine-induced myoclonus in guinea-pigs pretreated with a monoamine oxidase inhibitor indicates pre- and post-synaptic actions of tryptamine upon central indoleamine systemsG Luscombe, P Jenner, C D MarsdenEuropean Journal of Pharmacology|August 15, 1979
Changes in dopamine-mediated behaviour during one year's neuroleptic administrationA Clow, P Jenner, C D MarsdenBritish Journal of Pharmacology|March 1, 1987
Pharmacological characterization of binding sites identified in rat brain following in vivo administration of [3H]-spiperoneJ Chivers, P Jenner, C D MarsdenEuropean Journal of Pharmacology|February 11, 1986
Alterations in motor behaviour produced by the isomers of 3-PPP in the MPTP-treated marmosetM Nomoto, P Jenner, C D MarsdenPageof 1,101